121
Participants
Start Date
May 16, 2016
Primary Completion Date
June 23, 2020
Study Completion Date
August 18, 2020
BI 655064 dose 1
BI 655064 dose 2
BI 655064 dose 3
Placebo
Angeles University Foundation Medical Center, Angeles City
The Prince of Wales Hospital, Randwick
Princess Alexandra Hospital, Woolloongabba
Mary Mediatrix Medical Center, Lipa City, Batangas
Chong Hua Hospital, Cebu City
Cebu Doctors Hospital, Cebu City, Cebu
Southern Philippines Medical Center, Davao City
Columbia University Medical Center-New York Presbyterian Hospital, New York
King Chulalongkorn Memorial Hospital, Bangkok
Pramongkutklao Hospital, Bangkok
Siriraj Hospital, Bangkok
Institute of Rheumatology, Belgrade, Belgrade
Military Medical Academy, Belgrade
Northwell Health, Great Neck
Feinstein Institute for Medical Research, Manhasset
General University Hospital Prague 2, Nephrology Clinic, Prague
Institute of Rheumathology Prague, Prague
Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City
Instituto Nacional de Cs Médicas y Nutrición S Zubiran, Mexico City
Ajou University Hospital, Suwon
Clinical Centre Nis, Niš
Hospital Cardiologica Aguascalientes, Aguascalientes
Asklepios Klinik Altona, Hamburg
Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck
NZOZ Centrum Medyczne AESKULAP,Private Prac, Radom, Radom
Fundación Jiménez Díaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Emory University, Atlanta
Hospital Raja Permaisuri Bainun, Ipoh
Integrity Clinical Research, LLC, Doral
Integral Rheumatology and Immunology Specialist, Plantation
Hope Clinical Research, Kissimmee
Azienda Ospedaliera Universitaria di Padova, Padua
Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen
Office of Dr. Ramesh C. Gupta, Memphis
Hospital Tengku Ampuan Rahimah, Klang
Hospital Dr. Peset, Valencia
Hospital Hradec Kralove, Hradec Králové
Chiangmai University, Chiang Mai
Universitätsklinikum Köln (AöR), Cologne
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Naresuan University Hospital, Muang
Robert-Bosch-Krankenhaus GmbH, Stuttgart
HOP La Pitié Salpêtrière, Paris
H. Central Dr Ignacio M. P., San Luis Potosí City
Academic Medical Research Institute, Los Angeles
HOP Henri Mondor, Créteil
Prince of Wales Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
Toronto Western Hospital, Toronto
CHU de Quebec-Universite Laval Research Centre, Québec
"General Hospital of Athens Laiko", Athens
University General Hospital Attikon, Athens
University General Hospital of Heraklion, Heraklion, Crete
Hospital of the University of Occupational and Environmental Health, Fukuoka, Kitakyushu
Hokkaido University Hospital, Hokkaido, Sapporo
St. Marianna University School of Medicine Hospital, Kanagawa, Kawasaki
Tohoku University Hospital, Miyagi, Sendai
Okayama University Hospital, Okayama, Okayama
Juntendo University Hospital, Tokyo, Bunkyo-ku
Keio University Hospital, Tokyo, Shinjuku-ku
University Clinical Hospital in Bialystok I, Bialystok
Norbert Barlicki University Clinical Hospital No.1, Lodz, Lodz
Cent.Clin.Hosp.Med.Univ.Lodz,Electrocard, Lodz
Clinic Medical Center; Nowa Sol, Nowa Sól
John Paul II Regional Hospital, Zamosc, Zamość
CHUC - Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra
Hospital Curry Cabral, EPE, Lisbon
CHULN, EPE - Hospital de Santa Maria, Lisbon
Centro Hospitalar Universitário São João,EPE, Porto
Hospital Vall d'Hebron, Barcelona
Addenbrooke's Hospital, Cambridge
Leicester General Hospital, Leicester
Guy's Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY